Stryker Corporation (SYK): Today's Featured Health Services Winner

Stryker Corporation ( SYK) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.9%. By the end of trading, Stryker Corporation rose $0.79 (1.2%) to $68.22 on light volume. Throughout the day, 760,530 shares of Stryker Corporation exchanged hands as compared to its average daily volume of 1,355,100 shares. The stock ranged in a price between $67.34-$68.28 after having opened the day at $67.41 as compared to the previous trading day's close of $67.43. Other companies within the Health Services industry that increased today were: ImmunoCellular Therapeutics ( IMUC), up 15.1%, Organovo Holdings ( ONVO), up 13.3%, Given Imaging ( GIVN), up 10.3% and China Cord Blood ( CO), up 9.7%.

Stryker Corporation, a medical technology company, provides reconstructive, medical and surgical, and neurotechnology and spine products for doctors, hospitals, and other healthcare facilities. Stryker Corporation has a market cap of $25.5 billion and is part of the health care sector. Shares are up 22.9% year to date as of the close of trading on Friday. Currently there are 15 analysts that rate Stryker Corporation a buy, 1 analyst rates it a sell, and 12 rate it a hold.

TheStreet Ratings rates Stryker Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front, Mazor Robotics ( MZOR), down 8.5%, BSD Medical Corporation ( BSDM), down 6.8%, CardioNet ( BEAT), down 5.5% and Hooper Holmes ( HH), down 4.4% , were all laggards within the health services industry with Align Technology ( ALGN) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

These Stocks Are Ready to Reverse Course

Don't Get Out of Joint

Zimmer Biomet: Cramer's Top Takeaways

Market Stands at a Make-Or-Break Level: Cramer's 'Mad Money' Recap (Monday 7/17/17)

Analyst Says Rival Bidder Could Emerge for Novadaq After Stryker Deal